Second-generation antipsychotics: Reviewing the cost-effectiveness component of the CATIE trial

Robert Rosenheck, Marvin Swartz, Joseph Patrick McEvoy, T. Scott Stroup, Sonia Davis, Richard S.E. Keefe, John Hsiao, Jeffrey Lieberman

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Second-generation antipsychotics: Reviewing the cost-effectiveness component of the CATIE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences